Innovative cancer therapies start here
Committed to the development of innovative therapies for human and veterinary oncology applications, we are currently developing our main drug candidate ET-D5 for both applications simultaneously. In addition, we have several other R&D programs currently in the discovery phase.
Companion animals deserve the same innovative therapies than us. We will bring them ET-D5.